Physician profile
William L Washington
NPI 1083613806
$1,819.10
in general payments reported to CMS, 2019-2025
15 companies · $81.81 in 2025
The $81.81 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $647 · 2021: $193 · 2022: $125 · 2023: $14.80 · 2024: $16.02 · 2025: $81.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $704.94 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $310.95 | 2019-2020 | |
| Astellas Pharma US INC | $138.01 | 2019-2020 | |
| Amarin Pharma, INC. | $136.89 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $124.16 | 2019-2020 | |
| Abbott Laboratories | $81.81 | 2025 | Eterna, Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.31 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $58.93 | 2019-2021 | |
| Gilead Sciences, INC. | $41.12 | 2019 | |
| Amgen INC. | $31.74 | 2020 | |
| Exact Sciences Corporation | $30.82 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $29.72 | 2019-2020 | |
| Orexo US, INC. | $27.61 | 2019 | |
| Novo Nordisk INC | $16.26 | 2020 | |
| Glaxosmithkline, LLC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Washington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.